Pharmacodynamic effects of multiple doses of omapatrilat in healthy subjects.

被引：5
|
作者：
Vesterqvist, O [1 ]
Liao, W [1 ]
Manning, JA [1 ]
Uderman, HD [1 ]
Delaney, CL [1 ]
Swanson, BN [1 ]
机构：
[1] Bristol Myers Squibb PRI, Princeton, NJ USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1999年 / 65卷 / 02期
关键词：
D O I：
10.1016/S0009-9236(99)80061-7
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PI61
引用
收藏
页码：132 / 132
页数：1
相关论文
共 50 条
  • [31] SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS OF MULTIPLE DOSES OF INTRANASAL GLN-1062, A PRODRUG OF GALANTAMINE, IN HEALTHY ELDERLY SUBJECTS.
    Bakker, C.
    van der Aart, J.
    t Hart, E.
    Kay, D.
    Groeneveld, G.
    Maelicke, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S24 - S24
  • [32] Ethnicity and zopolrestat (Z) pharmacokinetics (PK) after multiple oral doses in normal, healthy Caucasian and Japanese subjects.
    Nishimi, Y
    Shah, AK
    Willavize, SA
    McNeill, SC
    Wood, AJJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P41 - P41
  • [33] PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTIONS BETWEEN EVOGLIPTIN AND METFORMIN AFTER ORAL ADMINISTRATION IN HEALTHY SUBJECTS.
    Rhee, S.
    Jang, K.
    Lee, J.
    Cho, Y.
    Choi, Y.
    Yoon, S.
    Cho, J.
    Lee, H.
    Yu, K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S51 - S51
  • [34] Effect of ketoconazole on the pharmacokinetic and pharmacodynamic properties of clopidogrel after oral administration in healthy subjects.
    Eum, S. Y.
    Kim, J. R.
    Lim, K. S.
    Kim, J. W.
    Kim, B. H.
    Kim, M. G.
    Chung, Y. J.
    Kim, T. E.
    Jeon, J. Y.
    Tae, Y. M.
    Cho, J. Y.
    Yu, K. S.
    Shin, S. G.
    Jang, I. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S78 - S78
  • [35] Transfusion of therapeutic doses of virally inactivated fresh frozen plasma in healthy subjects.
    Wages, D
    Smith, D
    Walsh, J
    Smyers, J
    Chen, C
    Moore, C
    Jue, C
    Davis, K
    Metzel, P
    Corash, L
    Cimino, G
    Hei, D
    Shafer, S
    Wiesehahn, G
    Buchholz, DH
    BLOOD, 1997, 90 (10) : 1818 - 1818
  • [36] PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTIONS BETWEEN EVOGLIPTIN AND PIOGLITAZONE AFTER ORAL ADMINISTRATION IN HEALTHY SUBJECTS.
    Jeon, I.
    Park, K.
    Hwang, I.
    Yoon, S.
    Lee, H.
    Yu, K-S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S38 - S38
  • [37] Pharmacokinetic and pharmacodynamic characteristics of ibandronate after a single intravenous infusion in healthy Korean subjects.
    Tae, Y. M.
    Lim, K. S.
    Kim, J. R.
    Kim, J. W.
    Kim, B. H.
    Jeon, J. Y.
    Yu, K. S.
    Shin, S. G.
    Jang, I. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S83 - S83
  • [38] Effects of cholecystokinin (CCK) on rectal sensitivity in healthy subjects.
    Gorbatchef, C
    Sabate, JM
    Collin, B
    Hourie, B
    Lemann, M
    Franchisseur, C
    Jian, R
    Rambaud, JC
    GASTROENTEROLOGY, 1997, 112 (04) : A738 - A738
  • [39] EFFECTS OF DRONEDARONE ON PHARMACOKINETICS AND PHARMACODYNAMICS OF LOSARTAN IN HEALTHY SUBJECTS.
    Bonnet, Denis
    Galleyrand, Jacques
    Brunet, Aurelie
    Sultan, Eric
    Gaud, Christine
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1080 - 1080
  • [40] Lack of pharmacokinetic interaction between multiple doses of the dipepttdyl peptidase-4 inhibitor alogliptin and digoxin in healthy subjects.
    Karim, A.
    Fleck, P.
    Harris, S.
    Weiss, M.
    Zhang, W.
    Mekki, Q.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S12 - S13
12345